Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224253820> ?p ?o ?g. }
- W4224253820 endingPage "308" @default.
- W4224253820 startingPage "298" @default.
- W4224253820 abstract "Although photodynamic therapy (PDT) has been well-known as a promising anti-tumor treatment, its limited therapeutic efficiency remains to be a large challenge. In this study, a carrier free nanomedicine (designated as PyroMor) is developed to greatly initiate cell apoptosis and paraptosis for synergistic cancer therapy. Pyropheophorbide-a (Pyro) and morusin (Mor) are capable of self-assembling into PyroMor, which has been testified to have superiority of improved stability, cellular internalization, and biocompatibility. Because of efficient cellular uptake behavior, PyroMor could induce cellular paraptosis by Mor-caused vacuolation in mitochondria, ER and cytoplasm, contributing to improving the PDT efficacy of Pyro. Therefore, self-delivery PyroMor is able to accomplish synergistic anti-tumor effect via stimulation of cell apoptosis as well as paraptosis. In addition, in vivo studies also clarify that PyroMor presents passive tumor targeting delivery, leading to robust repressive effect on tumor proliferation with negligible systemic toxicity. This strategy of combined cancer therapy by initiating both cell apoptosis and paraptosis extremely benefits to the development of precise and effective cancer therapy in clinic." @default.
- W4224253820 created "2022-04-26" @default.
- W4224253820 creator A5000601331 @default.
- W4224253820 creator A5000841815 @default.
- W4224253820 creator A5004455301 @default.
- W4224253820 creator A5016697633 @default.
- W4224253820 creator A5028072443 @default.
- W4224253820 creator A5039567363 @default.
- W4224253820 creator A5044784730 @default.
- W4224253820 creator A5057892877 @default.
- W4224253820 creator A5069391560 @default.
- W4224253820 creator A5082727079 @default.
- W4224253820 date "2022-09-01" @default.
- W4224253820 modified "2023-09-28" @default.
- W4224253820 title "Carrier free nanomedicine for synergistic cancer therapy by initiating apoptosis and paraptosis" @default.
- W4224253820 cites W1902809158 @default.
- W4224253820 cites W1990519098 @default.
- W4224253820 cites W2000725843 @default.
- W4224253820 cites W2006924113 @default.
- W4224253820 cites W2022830981 @default.
- W4224253820 cites W2030736494 @default.
- W4224253820 cites W2049262662 @default.
- W4224253820 cites W2070870649 @default.
- W4224253820 cites W2152764444 @default.
- W4224253820 cites W2242174805 @default.
- W4224253820 cites W2560191268 @default.
- W4224253820 cites W2580086132 @default.
- W4224253820 cites W2608687752 @default.
- W4224253820 cites W2614180073 @default.
- W4224253820 cites W2784329589 @default.
- W4224253820 cites W2789621285 @default.
- W4224253820 cites W2793964713 @default.
- W4224253820 cites W2809516562 @default.
- W4224253820 cites W2889400186 @default.
- W4224253820 cites W2895304668 @default.
- W4224253820 cites W2898765068 @default.
- W4224253820 cites W2934302086 @default.
- W4224253820 cites W2937456182 @default.
- W4224253820 cites W2941328763 @default.
- W4224253820 cites W2954118413 @default.
- W4224253820 cites W2974486256 @default.
- W4224253820 cites W2998097855 @default.
- W4224253820 cites W3002639883 @default.
- W4224253820 cites W3008219687 @default.
- W4224253820 cites W3011388471 @default.
- W4224253820 cites W3027187763 @default.
- W4224253820 cites W3037749543 @default.
- W4224253820 cites W3043355147 @default.
- W4224253820 cites W3080188533 @default.
- W4224253820 cites W3082093789 @default.
- W4224253820 cites W3086659331 @default.
- W4224253820 cites W3108453068 @default.
- W4224253820 cites W3109801031 @default.
- W4224253820 cites W3126281889 @default.
- W4224253820 cites W3137882913 @default.
- W4224253820 cites W3143846622 @default.
- W4224253820 cites W3171981776 @default.
- W4224253820 cites W3176117037 @default.
- W4224253820 cites W3196794485 @default.
- W4224253820 cites W3198332951 @default.
- W4224253820 cites W4206013364 @default.
- W4224253820 doi "https://doi.org/10.1016/j.jcis.2022.04.090" @default.
- W4224253820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35512593" @default.
- W4224253820 hasPublicationYear "2022" @default.
- W4224253820 type Work @default.
- W4224253820 citedByCount "4" @default.
- W4224253820 countsByYear W42242538202022 @default.
- W4224253820 countsByYear W42242538202023 @default.
- W4224253820 crossrefType "journal-article" @default.
- W4224253820 hasAuthorship W4224253820A5000601331 @default.
- W4224253820 hasAuthorship W4224253820A5000841815 @default.
- W4224253820 hasAuthorship W4224253820A5004455301 @default.
- W4224253820 hasAuthorship W4224253820A5016697633 @default.
- W4224253820 hasAuthorship W4224253820A5028072443 @default.
- W4224253820 hasAuthorship W4224253820A5039567363 @default.
- W4224253820 hasAuthorship W4224253820A5044784730 @default.
- W4224253820 hasAuthorship W4224253820A5057892877 @default.
- W4224253820 hasAuthorship W4224253820A5069391560 @default.
- W4224253820 hasAuthorship W4224253820A5082727079 @default.
- W4224253820 hasConcept C121608353 @default.
- W4224253820 hasConcept C126322002 @default.
- W4224253820 hasConcept C139770010 @default.
- W4224253820 hasConcept C1491633281 @default.
- W4224253820 hasConcept C15083742 @default.
- W4224253820 hasConcept C150903083 @default.
- W4224253820 hasConcept C155672457 @default.
- W4224253820 hasConcept C171250308 @default.
- W4224253820 hasConcept C185592680 @default.
- W4224253820 hasConcept C190283241 @default.
- W4224253820 hasConcept C192562407 @default.
- W4224253820 hasConcept C207001950 @default.
- W4224253820 hasConcept C2776999253 @default.
- W4224253820 hasConcept C2778448707 @default.
- W4224253820 hasConcept C2983331546 @default.
- W4224253820 hasConcept C502942594 @default.
- W4224253820 hasConcept C55493867 @default.
- W4224253820 hasConcept C71924100 @default.
- W4224253820 hasConcept C86803240 @default.